ABBV vs COST: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Costco Wholesale Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Costco Wholesale Corporation · Consumer Defensive
$896.48
+24.7% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
COST has more upside to fair value
(+24.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
COST |
| Current Price |
$261.70 |
$896.48 |
| Fair Value Estimate |
$259.04 |
$1,117.50 |
| Upside to Fair Value |
-1.0%
|
+24.7%
|
| Market Cap |
$462.4B |
$397.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
32.7x
|
| Price / Sales |
7.2x
|
1.3x
|
| Price / FCF |
23.6x
|
42.4x
|
| Revenue Growth YoY |
+10.2%
|
+11.1%
|
| Gross Margin |
71.5%
|
17.5%
|
| Operating Margin |
29.3%
|
3.9%
|
| Return on Equity |
-136.5%
|
28.0%
|
| Dividend Yield |
2.61% |
0.62% |
| FCF Yield |
4.25%
|
2.36%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Costco Wholesale Corporation operates a global network of membership-based warehouse clubs, selling branded and private-label merchandise across the United States, Canada, Mexico, Japan, the United Kingdom, South Korea, Taiwan, Australia, Spain, France, Iceland, and China, supplemented by pharmacies, optical centers, food courts, hearing aid centers, tire installation, 636 gas stations, and e-com…
Accumulation Zones
| Metric |
ABBV |
COST |
| Zone Low |
$194.28 |
$838.12 |
| Zone High |
$220.18 |
$949.88 |
| In Buy Zone? |
No
|
Yes
|